In previous work, our data showed that the short-term ex vivo incubation of an allogeneic graft with the non-depleting anti-human CD4 antibody MAX.16H5 IgG1 (murine) led to a significant GVHD reduction without negatively influencing the induced GVL effect (26). This evidence concerns the gene CD4 and graft versus host disease.